Now showing items 11-20 of 204
Uso de la tomografía de emisión de positrones PET con F18-FDG en la evaluación de lesiones pulmonares sospechosas de neoplasia
(Sociedad Médica de Santiago, 2005)
Current status of PET/CT in the diagnosis and follow up of lymphomas
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2011)
Lymphomas are a heterogeneous group of malignancies that have a distinct biological behavior according to the subtype and degree of differentiation. Adequate staging, which has a direct impact on prognosis, is essential ...
Positron emission tomography with fluorine-deoxyglucose in sarcomas and non-sarcoma non-epithelial tumors Utilidad del estudio PET con FDG en la evaluación de sarcomas de diverso origen y de tumores no sarcoma-no epiteliales
Background: The usefulness of positron emission tomography (PET) with fluorine-deoxyglucose (FDG) in sarcomas and non-sarcoma non-epithelial (NSNE) tumors is not clearly defined. Aim: To report a Chilean experience with ...
Probable Syphilitic Aortitis Documented by Positron Emission Tomography
(Lippincott, Williams & Wilkins, 2016)
Positron emission tomography (PET) has been used to aid in diagnosis of inflammatory and infectious disease. We describe the case of a patient with early latent syphilis with increased metabolic activity along the aorta ...
Transient aortitis documented by positron emission tomography in a case series of men and transgender women infected with syphilis
(BMJ Publishing Group, 2017)
OBJECTIVES: Syphilis infection persists globally contributing to preventable and treatable morbidity and mortality. How extensive early syphilis disseminates is unknown. To better understand the relationship between early ...
Changes in F18-flurodeoxyglucose uptake on serial cardiac positron emission tomography and left ventricular ejection fraction in patients with cardiac sarcoidosis
(American Heart AssociationDallas, 2013-11)
lntroduction: Cardiac positron emission tomography (PET) using F18-fluorodeoxyglucose (FDG) has been used to diagnose and monitor cardiac sarcoidosis (CS). It is not yet known whether a reduction in myocardial inflammation, ...